John F. Fraser
Papers
1
Total Citations
57
H-Index
1
About
John F. Fraser is a leading critical care researcher whose work bridges pharmacology, intensive care medicine, and translational science. His most-cited study, a 2012 paper on a high-throughput assay for simultaneous quantification of morphine, fentanyl, midazolam, and their major metabolites in plasma, has garnered 57 citations—a testament to its practical impact on clinical toxicology and pharmacokinetics. This work exemplifies Fraser’s focus on improving drug monitoring in critically ill patients, enabling safer, more precise sedation and pain management. Beyond this assay, his contributions span organ support technologies, including extracorporeal membrane oxygenation (ECMO) and sepsis pathophysiology, where he has advanced understanding of drug metabolism during critical illness. Fraser’s research is characterized by its direct clinical relevance, often translating complex analytical methods into bedside tools. His achievements include leadership roles in intensive care research networks and numerous collaborations that have shaped guidelines for sedation and analgesia in the ICU. For students and researchers, Fraser’s work demonstrates how rigorous analytical chemistry can solve real-world problems in patient care, making him a pivotal figure in the intersection of pharmacology and critical care medicine.
Research Focus
Key Achievements
Top Papers
- 1